Inventor · disambiguated record
Shawn David Erickson
Also filed as: ERICKSON SHAWN D · ERICKSON SHAWN DAVID · ERICKSON Shawn
40 granted patents·10 pending applications·232 citations·filing 1994–2024
97Inventor score
Top patents by PatentIndex Score
50 records- 0194US6432947B1N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 1999·Granted Aug 13, 2002·89 cites·34 claims
- 0287US7479495B2N-heterocyclic inhibitors of TNF-α expressionPHARMACOPEIA INC·Filed 2005·Granted Jan 20, 2009·11 cites·32 claims
- 0386US9296711B2Substituted isoxazole amide compounds as inhibitors of stearoyl-CoA desaturase 1 (SCD1)HOFFMANN LA ROCHE·Filed 2013·Granted Mar 29, 2016·9 cites·13 claims
- 0486US6906067B2N-heterocyclic inhibitors of TNF-α expressionPHARMACEOPEIA INC·Filed 2001·Granted Jun 14, 2005·35 cites·20 claims
- 0585US8729091B24-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compoundsHOFFMANN LA ROCHE·Filed 2013·Granted May 20, 2014·8 cites·12 claims
- 0684US2025031734A1Compositions comprising rebaudioside jPEPSICO INC·Filed 2024·Application pending·0 cites
- 0784US2023232878A1Compositions comprising rebaudioside jPEPSICO INC·Filed 2023·Application pending·0 cites
- 0882US10966447B2Glucosyringic acid analogs as sweetness profile modifiersPEPSICO INC·Filed 2016·Granted Apr 6, 2021·1 cites·14 claims
- 0982US9290465B2Substituted isoxazole amine compounds as inhibitors of SCD1HOFFMANN LA ROCHE·Filed 2013·Granted Mar 22, 2016·9 cites·14 claims
- 1081US2024108042A1Compositions and methods for enhancing sweetnessPEPSICO INC·Filed 2023·Application pending·0 cites
- 1178US8987307B23-amino-pyridines as GPBAR1 agonistsBISSANTZ CATERINA·Filed 2012·Granted Mar 24, 2015·4 cites·49 claims
- 1278US6747031B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Jun 8, 2004·6 cites·10 claims
- 1377US8420647B24-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compoundsBISSANTZ CATERINA·Filed 2011·Granted Apr 16, 2013·4 cites·16 claims
- 1477US5599926AA4 B6 macrotricyclic enantioselective receptors for amino acid derivatives, and other compoundsUNIV COLUMBIA·Filed 1994·Granted Feb 4, 1997·21 cites·4 claims
- 1576US7652053B2Diaminocycloalkane MCH receptor antagonistsHOFFMANN LA ROCHE·Filed 2007·Granted Jan 26, 2010·2 cites·19 claims
- 1676US6943161B2Pyrimidine and triazine kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted Sep 13, 2005·7 cites·30 claims
- 1775US8188098B2GPR119 receptor agonistsERICKSON SHAWN DAVID·Filed 2009·Granted May 29, 2012·5 cites·2 claims
- 1875US7652013B2Inhibitors of stearoyl-CoA desaturaseHOFFMANN LA ROCHE·Filed 2008·Granted Jan 26, 2010·2 cites·19 claims
- 1974US11582993B2Compositions comprising rebaudioside JPEPSICO INC·Filed 2017·Granted Feb 21, 2023·0 cites·2 claims
- 2074US7138529B2Substituted 3-cyanothiophene acetamides as glucagon receptor antagonistsHOFFMANN LA ROCHE·Filed 2004·Granted Nov 21, 2006·7 cites·36 claims
- 2173US6670473B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Dec 30, 2003·3 cites·8 claims
- 2271US10085472B2Compositions comprising rebaudioside JPEPSICO INC·Filed 2016·Granted Oct 2, 2018·0 cites·6 claims
- 2370US6841674B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Jan 11, 2005·2 cites·6 claims
- 2467US9693997B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Jul 4, 2017·1 cites·19 claims
- 2567US2020029608A1Compositions and methods for enhancing sweetnessPEPSICO INC·Filed 2018·Application pending·0 cites
- 2666US7037916B2Pyrimidine derivatives as IL-8 receptor antagonistsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted May 2, 2006·3 cites·33 claims
- 2766US6887865B2N-heterocyclic derivatives as NOS inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted May 3, 2005·1 cites·8 claims
- 2866US6849739B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Feb 1, 2005·1 cites·2 claims
- 2966US6846829B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Jan 25, 2005·1 cites·18 claims
- 3058US2014010783A1Antiviral compoundsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3155US6864263B2N-heterocyclic derivatives as NOS inhibitorsBERLEX LAB·Filed 2002·Granted Mar 8, 2005·0 cites·11 claims
- 3255US6841673B2N-heterocyclic derivatives as nos inhibitorsBERLEX LAB·Filed 2002·Granted Jan 11, 2005·0 cites·1 claims
- 3354US2005277642A1Pyrimidine kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2005·Application pending·0 cites
- 3451US10494397B2Rebaudioside analogsPEPSICO INC·Filed 2016·Granted Dec 3, 2019·0 cites·23 claims
- 3550US2014242028A1Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 3649US6864368B2N-heterocyclic derivatives as NOS inhibitorsBERLAX LAB INC·Filed 2002·Granted Mar 8, 2005·0 cites·1 claims
- 3746US7803816B2MCH receptor antagonistsHOFFMANN LA ROCHE·Filed 2006·Granted Sep 28, 2010·0 cites·16 claims
- 3845US9896433B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Feb 20, 2018·0 cites·15 claims
- 3944US8748434B21,2-pyridazines, 1,6-pyridazines and pyrimidinesHOFFMANN LA ROCHE·Filed 2013·Granted Jun 10, 2014·0 cites·15 claims
- 4042US10385022B23-amino-pyridines as GPBAR1 agonistsHOFFMANN LA ROCHE·Filed 2015·Granted Aug 20, 2019·0 cites·15 claims
- 4142US9511059B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Dec 6, 2016·0 cites·1 claims
- 4242US9394304B2Imidazopyridine derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Jul 19, 2016·0 cites·8 claims
- 4341US2015307461A1Antiviral compoundsBILOTTA JOSEPH A·Filed 2015·Application pending·0 cites
- 4438US2002065270A1N-heterocyclic inhibitors of TNF-alpha expressionFiled 2000·Application pending·0 cites
- 4536US9388172B2Substituted carbamate compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Jul 12, 2016·0 cites·8 claims
- 4636US9359337B2Acetamide derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Jun 7, 2016·0 cites·18 claims
- 4735US9388166B26-aminoindole derivatives as TRP channel antagonistsHOFFMANN LA ROCHE·Filed 2015·Granted Jul 12, 2016·0 cites·13 claims
- 4835US9353096B2Substituted phenylcarbamate compoundsHOFFMANN LA ROCHE·Filed 2015·Granted May 31, 2016·0 cites·17 claims
- 4934US9580411B2Substituted sulfonamide compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Feb 28, 2017·0 cites·14 claims
- 5033US2015218141A1Substituted carbamate compoundsHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shawn David Erickson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →